- Home
- ASTL vs LXRX Comparison
ASTL vs LXRX Comparison
Compare ASTL & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTL
- LXRX
- Stock Information
- Founded
- ASTL 1902
- LXRX 1995
- Country
- ASTL Canada
- LXRX United States
- Employees
- ASTL N/A
- LXRX N/A
- Industry
- ASTL Steel/Iron Ore
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- ASTL Industrials
- LXRX Health Care
- Exchange
- ASTL Nasdaq
- LXRX Nasdaq
- Market Cap
- ASTL 517.3M
- LXRX 428.8M
- IPO Year
- ASTL N/A
- LXRX 2000
- Fundamental
- Price
- ASTL $4.95
- LXRX $1.10
- Analyst Decision
- ASTL
- LXRX Buy
- Analyst Count
- ASTL 0
- LXRX 5
- Target Price
- ASTL N/A
- LXRX $3.23
- AVG Volume (30 Days)
- ASTL 1.0M
- LXRX 2.3M
- Earning Date
- ASTL 09-09-2025
- LXRX 08-06-2025
- Dividend Yield
- ASTL 5.14%
- LXRX N/A
- EPS Growth
- ASTL N/A
- LXRX N/A
- EPS
- ASTL N/A
- LXRX N/A
- Revenue
- ASTL $1,679,424,123.00
- LXRX $58,432,000.00
- Revenue This Year
- ASTL N/A
- LXRX N/A
- Revenue Next Year
- ASTL $28.05
- LXRX N/A
- P/E Ratio
- ASTL N/A
- LXRX N/A
- Revenue Growth
- ASTL N/A
- LXRX 1504.83
- 52 Week Low
- ASTL $4.17
- LXRX $0.28
- 52 Week High
- ASTL $12.14
- LXRX $2.18
- Technical
- Relative Strength Index (RSI)
- ASTL 46.53
- LXRX 52.33
- Support Level
- ASTL $4.83
- LXRX $1.10
- Resistance Level
- ASTL $5.11
- LXRX $1.23
- Average True Range (ATR)
- ASTL 0.21
- LXRX 0.06
- MACD
- ASTL 0.12
- LXRX -0.01
- Stochastic Oscillator
- ASTL 80.23
- LXRX 55.45
About ASTL Algoma Steel Group Inc.
Algoma Steel Group Inc is a fully integrated steel producer of hot and cold rolled steel products, including coiled sheet and plate, strategically located. The firm operates in a single segment of basic steel production including sheets, plates, slabs, and freights. The company's revenue is generated from contracts to produce, ship, and deliver steel products Geographically it serves Canada, the United States, and the rest of the world, whilst driving key revenue from domestic sales. The company generates the majority of its revenue from the sale of Steel sheets and strips.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.